Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
48.56
-0.06 (-0.12%)
At close: Mar 6, 2026, 4:00 PM EST
48.71
+0.15 (0.31%)
After-hours: Mar 6, 2026, 7:00 PM EST
Veradermics Market Cap
Veradermics has a market cap or net worth of $1.81 billion as of March 6, 2026.
Market Cap
1.81B
Enterprise Value
1.80B
1-Year Change
n/a
Ranking
Category
Stock Price
$48.56
Market Cap Chart
Since the IPO on February 4, 2026, Veradermics's market cap has increased from $1.32B to $1.81B, an increase of 36.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.81B | 36.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurinia Pharmaceuticals | 1.90B |
| Tyra Biosciences | 1.89B |
| Recursion Pharmaceuticals | 1.83B |
| Palvella Therapeutics | 1.81B |
| Zymeworks | 1.78B |
| Relay Therapeutics | 1.77B |
| Definium Therapeutics | 1.76B |
| Enliven Therapeutics | 1.76B |